Discover 156 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 156
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: Eugene OR, Surrey, Reno NV, Walnut Creek CA, Solvang CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase 3, Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Location: Eugene OR, Denver CO, Dallas TX, Chicago IL, Houston TX,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT06465953
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Eugene OR, Panorama City CA, Los Angeles CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227298
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Eugene OR, Vancouver WA, Long Beach CA, Lone Tree CO,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase 2, Recruiting
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
for
Endometrioid Endometrial Cancer
Location: Eugene OR, Tucson AZ, Minneapolis MN, Fort Worth TX,
Sponsor: Traws Pharma, Inc.
Sex: Female
Age: 18+
Code: NCT05705505
Phase 1, Phase 2, Recruiting
MYLUNG Consortium Part 3: Observational Study
for
Carcinoma, Non-Small-Cell Lung
Location: Eugene OR, Vancouver WA, Chicago Ridge IL,
Sponsor: US Oncology Research
Sex: All
Age: 18+
Code: NCT05885698
Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Eugene OR, Palo Alto CA, Henderson NV, Duarte CA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase 2, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Eugene OR, Portland OR, Redding CA, Seattle WA,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Eugene OR, Portland OR, Vancouver WA, Medford OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Eugene OR, Portland OR, Seattle WA, San Francisco CA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Eugene OR, Salem OR, Vancouver WA, Vancouver,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase 2, Phase 3, Recruiting
Mechanisms of Depression and Anhedonia in Adolescents: Linking Sleep to Reward- and Stress-Related Brain Function
for
Depression in Adolescence
Location: Eugene OR
Sponsor: University of Oregon
Sex: All
Age: 14 - 18
Code: NCT05691439
Recruiting
Garden-fresh Foods and Gut Microbiomes
for
Gut Microbiome
Location: Eugene OR
Sponsor: University of Oregon
Sex: All
Age: 18 - 45
Code: NCT06506786
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Eugene OR, Bellevue WA, Walnut Creek CA, Stanford CA,